HEALTH CDMO Division is a prominent player in the pharmaceutical industry, specialising in the provision of cGMP clinical manufacturing services. As the Contract Development and Manufacturing Organisation (CDMO) arm of Lubrizol Life Science Health (LLS Health), it delivers a comprehensive suite of services supported by robust in-house cGMP analytical services, bioanalytical services, and particle characterisation. The division focuses on Active Pharmaceutical Ingredients, Biopharmaceuticals, Finished Dosage Formulation, and Packaging, catering to the diverse needs of drug developers throughout the clinical trial phases.

Services include:
- Clinical Trials
- Contract Development and Manufacturing (CDMO)
- Contract Manufacturing (CMO)
- Drug Development
- Excipients
- Process Development
- Lyophilisation
- Manufacturing
- Aseptic Fill-Finish
- Biologics
- Cytotoxic & High Potency Compounds
- Dose Form
- Sterile
- Injectables
- Nasal Delivery
- Ophthalmics
- Solutions & Suspensions

HEALTH CDMO Division is dedicated to advancing pharmaceutical development through its extensive capabilities and expertise. For more information, please visit lubrizolcdmo.com.